Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Deborah ConstantJane HarriesThokozile MalabaLandon MyerMalika PatelGregory PetroDaniel GrossmanPublished in: PloS one (2016)
The introduction of a combined mifepristone-misoprostol regimen into public sector second-trimester medical abortion services in South Africa has been successful with shorter time-to-abortion events, less extreme pain and greater acceptability for women. High rates of uterine evacuation for placental tissue need to be addressed.
Keyphrases
- south africa
- healthcare
- pregnancy outcomes
- mental health
- polycystic ovary syndrome
- hiv positive
- primary care
- preterm birth
- pregnant women
- chronic pain
- cervical cancer screening
- breast cancer risk
- gestational age
- climate change
- neuropathic pain
- type diabetes
- adipose tissue
- metabolic syndrome
- skeletal muscle
- men who have sex with men
- adverse drug